A N⁷-Methylguanine-Related Gene Signature Applicable for the Prognosis and Microenvironment of Prostate Cancer

Table 1

Clinical characteristics of the PRAD patients in different risk groups.

Clinical characteristics (samples)	TCGA cohort (339)		GSE116918 cohort (248)
	Low risk	High risk	Low risk	High risk
Age (years)
<65	156	70	47	28
≥65	70	43	118	55
Pathologic N
N0	199	82
N1	27	31
Pathologic T
T1+T2	115	28
T3+T4	111	85
Gleason score
<=6	14	5	26	16
=7	126	44	58	41
>=8	86	64	81	26
PSA (ng/ml)
<20			96	46
>=20			69	37